Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001
Status:
Completed
Trial end date:
2016-09-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the efficacy, safety, and tolerability of
fulranumab as adjunctive therapy compared with placebo in participants with chronic moderate
to severe pain and functional impairment from knee or hip osteoarthritis that is not
adequately controlled by current pain therapy.